Skip to content

A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome

A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01669889
Enrollment
38
Registered
2012-08-21
Start date
2013-01-31
Completion date
2013-12-31
Last updated
2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer, Autistic Disorder, Asperger's Syndrome

Brief summary

This multi-center, non-drug study will explore the relationship between exploratory biomarkers and functional dimensions in male adult individuals with Autistic Disorder or Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of assessments on study visit Day 1.

Interventions

None listed

Sponsors

Hoffmann-La Roche
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Individuals with Autistic Disorder or Asperger's Syndrome: * Male adults, 18 to 45 years of age inclusive * Diagnosis of Autistic Disorder or Asperger's Syndrome as defined by DSM-IV * IQ \>70 * Body mass index (BMI) 18 to 35 kg/m2 * Availability of a reliable caregiver, able and willing to provide information regarding the individual's behavior and symptoms Healthy controls: * Healthy male adults, 18 to 45 years of age inclusive * IQ \>70 * Body mass index (BMI) 18 to 30 kg/m2

Exclusion criteria

General

Design outcomes

Primary

MeasureTime frame
Behavior assessment ratingsapproximately 5 months
Cognition assessment ratingsapproximately 5 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026